biological source
mouse
Quality Level
antibody form
purified immunoglobulin
antibody product type
primary antibodies
clone
L2, monoclonal
species reactivity
human
manufacturer/tradename
Chemicon®
technique(s)
ELISA: suitable, immunofluorescence: suitable, western blot: suitable
isotype
IgG1
shipped in
wet ice
Application
免疫荧光
ELISA
免疫印迹（弱）
最佳稀释度必须由最终用户确定。
ELISA
免疫印迹（弱）
最佳稀释度必须由最终用户确定。
抗EBV VCA gp125抗体，克隆L2是一种抗EBV VCA gp125的抗体，用于ELISA、IF & WB。
研究子类别
传染病 - 病毒
传染病 - 病毒
研究类别
传染病
传染病
Biochem/physiol Actions
VCA-gp125
Physical form
形式：纯化
纯化的免疫球蛋白。 溶于0.02 M磷酸盐缓冲液、0.25 M氯化钠（pH=7.6）和0.1%叠氮化钠中。
Preparation Note
维持在2-8°C。
Other Notes
浓度：关于批次特定浓度请参见检验报告。
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
除非我们的目录或产品随附的其他公司文件中另有说明，否则我们的产品预期仅用于研究用途，不得用于任何其他目的，包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或对人类或动物的任何类型的消费或应用。
Still not finding the right product?
试用我们的 产品选型工具 工具缩小选择范围
存储类别
12 - Non Combustible Liquids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
Katerina Vrzalikova et al.
Blood, 117(22), 5907-5917 (2011-03-18)
An important pathogenic event in Epstein-Barr virus (EBV)-associated lymphomas is the suppression of virus replication, which would otherwise lead to cell death. Because virus replication in B cells is intimately linked to their differentiation toward plasma cells, we asked whether
Glycoprotein gp110 of Epstein-Barr virus determines viral tropism and efficiency of infection.
Neuhierl, B; Feederle, R; Hammerschmidt, W; Delecluse, HJ
Proceedings of the National Academy of Sciences of the USA null
Primary B-cell infection with a deltaBALF4 Epstein-Barr virus comes to a halt in the endosomal compartment yet still elicits a potent CD4-positive cytotoxic T-cell response.
Bernhard Neuhierl,Regina Feederle,Dinesh Adhikary,Birgit Hub,Karsten Geletneky et al.
Journal of virology null
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| MAB8184 | 04053252267963 |